Background: Hypoalbuminemia is an independent risk factor for mortality and is associated with malnutrition. One of the factors involved in the etiology of hypoalbuminemia and malnutrition is dialysate protein loss during CAPD. Objective: We report the characteristic of serum albumin, one of the nutritional indicators, in patients with the course of CAPD for at least 5 years. Methods: A retrospective analysis was done on CAPD patients who started CAPD during 1 May 1993 to 31 December 1997. The serum albumin level was monitored for 5 years. Results: 56 patients were included. All were on CAPD with Dianeal. Age, gender, and peritoneal transporter status distribution were normal. There was no significant difference in the serum albumin and residual renal function on commencement of CAPD. Serum albumin decreased with time. The decrease is marked at the 5 th year. Thirteen (23%) patients died in the 6 th year.
Year
Average Objective: Regular pre-dialysis education classes (PEC) were delivered to patients suffering from chronic kidney disease (CKD) before the start of routine dialysis in a regional hospital. We assessed the effect of PEC on CKD patients.
Methods:
This was a prospective observational study. 12 PECs were organized from 1996 to 2000. 107 (44 male, 63 female) CKD patients and their families who attended PEC (group A) were compared with 285 CKD patients (147 male, 138 female) who did not attend PEC (group B) before their enrollment into the CAPD program. Both groups underwent the same structured PD training after Tenckhoff catheter insertion. Patients were evaluated at the break-in period, and 3 and 6 months after the commencement of routine dialysis. Results: During the break-in period, the requirements of intermittent hemodialysis (IHD) support and hospitalization rate (HR) were significantly higher in group B when compared with group A (IHD: 4.6 6.6 in group A and 6.7 8.2 in group B, p < 0.01; HR: 12.2 13.7 days in group A and 20.5 16.1 days in group B, p = 0.02). There were also more non-scheduled nephrologist consultations (NSFU) in group B patients, both at 3 and 6 months after commencement of PD, although it did not reach statistical significance (p = 0.06). Conclusions: PEC reduces the need for early hospitalization and IHD support in the break-in period. The effect seems persistent as long as 6 months after commencement of PD as reflected by the lower needs of extra NSFU. Objective: International studies have shown that interleukin-2 receptor antagonist (IL2RA) is effective in preventing acute rejection in renal transplant recipients (RTR). We conducted a single center prospective study to assess its efficacy in Chinese RTR. Methods: All RTR treated with IL2RA in a tertiary transplant hospital were recruited from 1999 to 2001 (group 1). Its efficacy was assessed by comparing with RTR who were either treated with antithymocyte globulin (ATG) as induction therapy or without induction therapy from 1997 to 2001 (group 2). Results: Group 1 comprised 24 RTR (13 male, 11 female) while group 2 recruited 33 controls (19 male, 14 female). Creatinine upon hospital discharge was lower in group 1 (220 127.4 M) compared with group 2 (356 340.9 M) (p = 0.02). There was also a trend of lower serum creatinine at 6 and 12 months after renal transplantation but it did not reach statistical significance. The initial post-transplant length of stay and first year hospitalization rate as well as complications including the development of acute and chronic rejections, patient and graft survival within 2 years and posttransplant infection and malignancy showed no significant difference. The incidence of biopsy proven acute rejection was 16% in group 1 compared to 9% in group 2 (p > 0.05). Conclusions: IL2RA is effective in Chinese RTR with improvement of serum creatinine after renal transplantation without increasing the risk of complications and hospitalizations.
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